股本结构
单位：万股
| 公告日期 | 2025-11-12 | 2025-11-12 | 2025-09-05 | 2025-08-18 | 2025-09-05 | 2025-06-13 |
|---|---|---|---|---|---|---|
| 证券总股本 | 2248.73 | 2025.46 | 1965.46 | 1965.46 | 1934.92 | 1621.93 |
| 普通股本 | 2248.73 | 2025.46 | 1965.46 | 1965.46 | 1934.92 | 1621.93 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-11-10 | 2025-09-30 | 2025-09-04 | 2025-08-11 | 2025-06-30 | 2025-06-12 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-11-12 | 2248.73 | 未披露 | 定期报告 | 2025-11-10 |
| 2025-11-12 | 2025.46 | 未披露 |
更多>>
From July 1, 2025 to September 30, 2025
Common stock issued
|
2025-09-30 |
| 2025-09-05 | 1965.46 | 未披露 | 定期报告 | 2025-09-04 |
| 2025-08-18 | 1965.46 | 未披露 | 定期报告 | 2025-08-11 |
| 2025-09-05 | 1934.92 | 未披露 |
更多>>
From June 30, 2024 to June 30, 2025
Common stock issued
Exercise of stock options
Vesting of RSUs
AstralBio Exclusive License Agreement shares issued
Warrant Inducement Transaction
|
2025-06-30 |
| 2025-06-13 | 1621.93 | 未披露 | 定期报告 | 2025-06-12 |
| 2025-05-02 | 1651.93 | 未披露 | 定期报告 | 2025-05-01 |
| 2025-05-02 | 1006.63 | 未披露 |
更多>>
From December 31, 2024 to March 31, 2025
Common stock issued
Exercise of stock options
Vesting of RSUs
AstralBio Exclusive License Agreement shares issued
|
2025-03-31 |
| 2025-02-10 | 987.47 | 未披露 | 定期报告 | 2025-02-07 |
| 2025-01-31 | 983.16 | 未披露 | 定期报告 | 2025-01-28 |
| 2025-02-10 | 916.77 | 未披露 |
更多>>
From September 30, 2024 to December 31, 2024
Common stock issued
Exercise of stock options
Vesting of RSUs
|
2024-12-31 |
| 2024-11-12 | 914.95 | 未披露 | 定期报告 | 2024-11-12 |
| 2024-10-10 | 913.79 | 未披露 | 定期报告 | 2024-10-09 |
| 2024-11-12 | 863.79 | 未披露 |
更多>>
From July 1, 2024 to September 30, 2024
Common stock issued for warrants exercised
Vesting of RSUs
|
2024-09-30 |
| 2024-09-20 | 863.79 | 未披露 | 定期报告 | 2024-09-19 |
| 2024-07-25 | 862.37 | 未披露 | 定期报告 | 2024-07-19 |
| 2024-09-20 | 862.37 | 未披露 |
更多>>
From June 30, 2023 to June 30, 2024
Capital raises
Payments for fractional shares resulting from reverse stock split
Vesting of RSUs
|
2024-06-30 |
| 2024-08-06 | 861.26 | 未披露 | 定期报告 | 2024-06-13 |
| 2024-05-13 | 862.37 | 未披露 | 定期报告 | 2024-05-09 |
| 2024-04-16 | 861.14 | 未披露 | 定期报告 | 2024-04-16 |
| 2024-05-13 | 851.74 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Capital raise
Vesting of RSUs
|
2024-03-31 |
| 2024-02-09 | 348.43 | 未披露 | 定期报告 | 2024-02-08 |
| 2024-02-09 | 324.37 | 未披露 |
更多>>
From September 30,2023 to December 31,2023
Capital raise
Payment for fractional shares after reverse stock split
Vesting of RSUs
|
2023-12-31 |
| 2023-12-06 | 365.50 | 未披露 |
更多>>
Common stock offered 2,250,000 shares by the company
|
2023-12-07 |
| 2023-11-28 | 140.50 | 未披露 |
更多>>
iBio, Inc. announced that its Board of Directors has approved a 20-to-1 reverse split of the Company’s common stock, par value $0.001 per share (the “Common Stock”) effective at 12:01 a.m. ET on November 29, 2023 (the “Effective Date”).
|
2023-11-29 |
| 2023-10-27 | 2810.07 | 未披露 | 定期报告 | 2023-10-27 |
| 2023-10-26 | 2808.99 | 未披露 | 定期报告 | 2023-10-25 |
| 2023-11-14 | 2765.36 | 未披露 |
更多>>
From July 1, 2023 to September 30, 2023
Capital raise
Vesting of RSUs
Costs to raise capital
|
2023-09-30 |
| 2023-09-27 | 2758.65 | 未披露 | 定期报告 | 2023-09-26 |
| 2023-08-14 | 2261.21 | 未披露 | 定期报告 | 2023-08-04 |
| 2023-09-27 | 2031.01 | 未披露 |
更多>>
From June 30, 2022 to June 30, 2023
Capital raises
Asset acquisition
Payments for fractional shares resulting from reverse stock split
Vesting of RSUs
|
2023-06-30 |
| 2023-05-15 | 1679.80 | 未披露 | 定期报告 | 2023-05-10 |
| 2023-05-15 | 1581.81 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Capital raise
Vesting of RSUs
|
2023-03-31 |
| 2023-02-14 | 1236.92 | 未披露 | 定期报告 | 2023-02-07 |
| 2023-02-14 | 1236.83 | 未披露 |
更多>>
From September 30, 2022 to December 31, 2022
Capital raise
Payment for fractional shares after reverse stock split
Vesting of RSUs
|
2022-12-31 |
| 2022-12-08 | 1051.96 | 未披露 |
更多>>
Common Stock offered 1,530,769 shares by the company
|
2022-12-09 |
| 2022-11-14 | 898.88 | 未披露 | 定期报告 | 2022-11-07 |
| 2022-09-27 | 900.66 | 未披露 |
更多>>
On September 22, 2022, the Board approved the Reverse Stock Split at a ratio of one (1) share of Common Stock for every twenty-five (25) shares of Common Stock issued and outstanding.
|
2022-10-10 |
| 2022-09-27 | 22516.46 | 未披露 | 定期报告 | 2022-09-27 |
| 2022-05-12 | 21816.56 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Vesting of RSUs
|
2022-03-31 |
| 2022-02-14 | 21808.23 | 未披露 | 定期报告 | 2022-01-26 |
| 2022-02-14 | 21806.06 | 未披露 |
更多>>
From September 30, 2021 to December 31, 2021
Vesting of RSUs
|
2021-12-31 |
| 2021-10-26 | 21795.76 | 未披露 | 定期报告 | 2021-10-15 |
| 2021-09-28 | 21787.31 | 未披露 |
更多>>
From June 30, 2020 to June 30, 2021
Capital raises
Exercise of stock options
Vesting of RSU's
Conversion of preferred stock to common stock
|
2021-06-30 |
| 2021-05-17 | 21785.03 | 未披露 | 定期报告 | 2021-05-17 |
| 2021-05-17 | 21613.35 | 0.0001 |
更多>>
From December 31, 2020 To March 31, 2021
Capital raises
Costs to raise capital
|
2021-03-31 |
| 2021-02-16 | 21600.99 | 未披露 | 定期报告 | 2021-02-16 |
| 2021-02-16 | 21176.91 | 0.0001 |
更多>>
From September 30, 2020 to December 31, 2020
Capital raises
|
2020-12-31 |
| 2020-12-10 | 20997.88 | 未披露 |
更多>>
1.Common stock offered by the company pursuant to this prospectus supplement 29,661,017 shares.
2.The number of shares of common stock that will be outstanding immediately after this offering as shown above is based on 180,317,751 shares outstanding as of September 30, 2020.
|
2020-12-10 |
| 2020-11-16 | 18210.81 | 未披露 | 定期报告 | 2020-11-16 |
| 2020-10-13 | 18028.78 | 未披露 | 定期报告 | 2020-10-08 |
| 2020-11-16 | 18031.78 | 0.58 |
更多>>
From July 1, 2020 to September 30, 2020
Conversion of preferred stock to common stock
Exercise of stock options
Capital raises
|
2020-09-30 |
| 2020-10-13 | 14007.11 | 0.58 |
更多>>
From July 1, 2019 to June 30, 2020
Sales of Series C Preferred and common stock
Conversion of preferred stock to common stock
Compensation shares
Exercise of warrants
Exercise of stock options
Warrant exchange and deemed dividend
|
2020-06-30 |
| 2020-06-17 | 11979.57 | 0.58 | 定期报告 | 2020-06-11 |
| 2020-05-15 | 11836.00 | 未披露 | 定期报告 | 2020-05-15 |
| 2020-05-15 | 10736.00 | 0.58 |
更多>>
From December 31, 2019 to March 31, 2020
Warrant exchange
Capital raise
Compensation shares
Exercise of warrants
Exercise of stock options
Conversion of preferred stock to common stock
|
2020-03-31 |
| 2020-03-20 | 10144.42 | 0.58 | 定期报告 | 2020-03-18 |
| 2020-02-14 | 7619.55 | 未披露 | 定期报告 | 2020-02-12 |
| 2020-01-23 | 5932.75 | 0.58 | 定期报告 | 2020-01-13 |
| 2020-02-14 | 5456.75 | 0.58 |
更多>>
From September 30, 2019 to December 31, 2019
Capital raise
Compensation shares
Exercise of warrants
Conversion of preferred stock to common stock
|
2019-12-31 |
| 2019-11-14 | 3192.75 | 未披露 | 定期报告 | 2019-11-12 |
| 2019-10-29 | 2660.25 | 未披露 | 定期报告 | 2019-10-29 |
| 2019-11-14 | 2415.25 | 0.62 |
更多>>
From June 30, 2019 to September 30, 2019
Conversion of preferred stock to common stock
|
2019-09-30 |
| 2019-08-26 | 2415.25 | 未披露 | 定期报告 | 2019-08-26 |
| 2019-08-26 | 2015.25 | 0.98 |
更多>>
from July 1, 2018 to June 30, 2019
Conversion of preferred stock to common stock
Issuance of common stock to underwriters
|
2019-06-30 |
| 2019-05-10 | 1970.25 | 未披露 | 定期报告 | 2019-05-09 |
| 2019-05-10 | 1960.25 | 1.03 |
更多>>
from December 31, 2018 to March 31, 2019
Conversion of preferred stock to common stock
Issuance of common stock to underwriters
|
2019-03-31 |
| 2019-02-13 | 1903.68 | 未披露 | 定期报告 | 2019-02-04 |
| 2019-02-13 | 1883.68 | 1.08 |
更多>>
From July 1, 2018 to December 31, 2018
Sales of common stock
Conversion of preferred stock to common stock
|
2018-12-31 |
| 2018-11-19 | 1868.68 | 1.10 | 定期报告 | 2018-11-16 |
| 2018-11-13 | 1863.68 | 未披露 | 定期报告 | 2018-11-13 |
| 2018-11-13 | 1833.68 | 1.13 |
更多>>
From July 1, 2018 to September 30, 2018
Conversion of preferred stock to common stock
Sale of common stock
|
2018-09-30 |
| 2018-09-18 | 1833.68 | 未披露 | 定期报告 | 2018-09-14 |
| 2018-09-18 | 1828.68 | 未披露 | 定期报告 | 2018-08-31 |
| 2018-09-18 | 1604.01 | 1.20 |
更多>>
From July 1, 2017 to June 30, 2018
Sales of preferred stock
Sales of common stock
Commitment fees for issuance of common stock
Cash in lieu for fractional shares
Conversion of preferred stock to common stock
|
2018-06-30 |
| 2018-06-11 | 1159.18 | 0.0001 |
更多>>
IBIO, INC.(NYSE AMERICAN:IBIO) announced today a reverse split of its Common Stock, par value $0.001 per share (the "Common Stock"), at a ratio of 1 for 10, effective on June 8, 2018 (the "Effective Date"). The Company's common stock will continue to trade on the New York Stock Exchange under the trading symbol "IBIO" but will trade under the new CUSIP number 451033 203. As a result of the reverse split, each ten pre-split shares of common stock outstanding will automatically combine into one new share of common stock without any action on the part of the holders, and the number of outstanding common shares will be reduced from 115,918,510 shares to 11,591,851 shares.
|
2018-06-11 |
| 2018-05-11 | 11591.85 | 0.0001 |
更多>>
From July 1, 2017 To March 31, 2018
Sales of common stock
Commitment fees for issuance of common stock
|
2018-03-31 |
| 2018-02-14 | 11531.85 | 0.0001 |
更多>>
From July 1, 2017 To December 31, 2017
Sale of common stock
Commitment fee for issuance of common stock
|
2017-12-31 |
| 2017-11-09 | 9281.85 | 0.0001 |
更多>>
From July 1, 2017 To September 30, 2017
Sale of common stock
Commitment fee for issuance of common stock
|
2017-09-30 |
| 2017-09-15 | 9281.85 | 未披露 | 定期报告 | 2017-09-15 |
| 2017-05-15 | 8911.85 | 0.0001 |
更多>>
From July 1, 2016 to March 31, 2017
Other adjustment
|
2017-03-31 |
| 2016-10-13 | 8910.94 | 未披露 |
更多>>
From July 1, 2015 to June 30, 2016
Sale of common stock
Exercises of warrants
|
2016-06-30 |
| 2016-05-23 | 8910.94 | 未披露 | 定期报告 | 2016-05-23 |
| 2016-05-23 | 8260.94 | 未披露 |
更多>>
from July 1, 2015 to March 31, 2016
Sale of common stock
Exercises of warrants
|
2016-03-31 |
| 2016-02-22 | 8260.94 | 未披露 | 定期报告 | 2016-02-19 |
| 2015-11-13 | 7732.54 | 未披露 |
更多>>
from July 1, 2015 to September 30, 2015
Exercise of warrants
|
2015-09-30 |
| 2015-10-13 | 7720.54 | 未披露 |
更多>>
from July 1, 2014 to June 30, 2015
Sale of common stock
Commitment fee
Exercises of warrants
|
2015-06-30 |
| 2015-05-15 | 7675.54 | 未披露 | 定期报告 | 2015-05-15 |
| 2015-05-15 | 7407.10 | 未披露 |
更多>>
from July 1, 2014 to March 31, 2015
Sale of common stock
Commitment fee
Exercises of warrants
|
2015-03-31 |
| 2015-02-23 | 7398.14 | 未披露 | 定期报告 | 2015-02-23 |
| 2015-02-23 | 7198.14 | 未披露 |
更多>>
from July 1, 2014 to December 31, 2014
Sale of common stock
Commitment fee
Exercises of warrants
|
2014-12-31 |
| 2014-11-12 | 7190.14 | 未披露 | 定期报告 | 2014-11-10 |
| 2014-11-14 | 6746.03 | 未披露 |
更多>>
from July 1, 2014 to September 30, 2014
Capital contribution and commitment fee
|
2014-09-30 |
| 2014-09-29 | 6746.03 | 未披露 | 定期报告 | 2014-09-26 |
| 2014-09-29 | 6564.21 | 未披露 |
更多>>
from June 30, 2013 to June 30, 2014
Common stock issued for warrant exercises
Common stock issued for private placement
|
2014-06-30 |
| 2014-02-14 | 6444.21 | 未披露 |
更多>>
from July 1, 2013 to December 31, 2013
Common stock issued for warrant exercises
|
2013-12-31 |
| 2013-11-18 | 6564.21 | 未披露 | 定期报告 | 2013-11-15 |
| 2013-11-14 | 6444.21 | 未披露 | 定期报告 | 2013-10-31 |
| 2013-11-04 | 6419.21 | 未披露 | 定期报告 | 2013-10-15 |
| 2013-09-30 | 5669.21 | 未披露 |
更多>>
from June 30, 2012 to May 15, 2013
Issuance of common stock in connection with January 2012 equity offering, net of expenses
|
2013-05-15 |
| 2012-10-12 | 4776.71 | 未披露 |
更多>>
from June 30, 2011 to February 14,2012
Issuance of common stock and warrants in January 2012, at $0.65 per unit, net of expenses
|
2012-02-14 |
| 2011-05-18 | 3238.21 | 未披露 |
更多>>
from June 30 2010 to March 31 2011
Issuance of common stock and warrants between October 27, 2010 and November 22, 2010 for cash at $2.00 per unit, net of expenses
Issuance of common stock between October 27, 2010 and November 22, 2010 in accordance with anti-dilution provisions of the August 2008 financing
Issuance of common stock in connection with exercise of warrants
|
2011-03-31 |
| 2011-02-14 | 3236.23 | 未披露 | 定期报告 | 2011-02-11 |
| 2011-02-14 | 3229.23 | 未披露 |
更多>>
from June 30 2010 to December 31 2010
Issuance of common stock and warrants for cash at $2.00 per unit, net of expenses
Issuance of common stock in accordance with anti-dilution provisions of the August 2008 financing
|
2010-12-31 |
| 2010-11-15 | 3180.52 | 未披露 | 定期报告 | 2010-11-12 |
| 2010-05-19 | 2827.27 | 未披露 |
更多>>
from June 30 2009 to March 31 2010
Issuance of common stock and warrants for cash at $0.65 per unit, net of expenses
Issuance of common stock in accordance with anti-dilution provisions of the August 2008 financing
|
2010-03-31 |
From July 1, 2025 to September 30, 2025
Common stock issued
From June 30, 2024 to June 30, 2025
Common stock issued
Exercise of stock options
Vesting of RSUs
AstralBio Exclusive License Agreement shares issued
Warrant Inducement Transaction
From December 31, 2024 to March 31, 2025
Common stock issued
Exercise of stock options
Vesting of RSUs
AstralBio Exclusive License Agreement shares issued
From September 30, 2024 to December 31, 2024
Common stock issued
Exercise of stock options
Vesting of RSUs
From July 1, 2024 to September 30, 2024
Common stock issued for warrants exercised
Vesting of RSUs
From June 30, 2023 to June 30, 2024
Capital raises
Payments for fractional shares resulting from reverse stock split
Vesting of RSUs
From December 31, 2023 to March 31, 2024
Capital raise
Vesting of RSUs
From September 30,2023 to December 31,2023
Capital raise
Payment for fractional shares after reverse stock split
Vesting of RSUs
Common stock offered 2,250,000 shares by the company
iBio, Inc. announced that its Board of Directors has approved a 20-to-1 reverse split of the Company’s common stock, par value $0.001 per share (the “Common Stock”) effective at 12:01 a.m. ET on November 29, 2023 (the “Effective Date”).
From July 1, 2023 to September 30, 2023
Capital raise
Vesting of RSUs
Costs to raise capital
From June 30, 2022 to June 30, 2023
Capital raises
Asset acquisition
Payments for fractional shares resulting from reverse stock split
Vesting of RSUs
From December 31, 2022 to March 31, 2023
Capital raise
Vesting of RSUs
From September 30, 2022 to December 31, 2022
Capital raise
Payment for fractional shares after reverse stock split
Vesting of RSUs
Common Stock offered 1,530,769 shares by the company
On September 22, 2022, the Board approved the Reverse Stock Split at a ratio of one (1) share of Common Stock for every twenty-five (25) shares of Common Stock issued and outstanding.
From December 31, 2021 to March 31, 2022
Vesting of RSUs
From September 30, 2021 to December 31, 2021
Vesting of RSUs
From June 30, 2020 to June 30, 2021
Capital raises
Exercise of stock options
Vesting of RSU's
Conversion of preferred stock to common stock
From December 31, 2020 To March 31, 2021
Capital raises
Costs to raise capital
From September 30, 2020 to December 31, 2020
Capital raises
1.Common stock offered by the company pursuant to this prospectus supplement 29,661,017 shares.
2.The number of shares of common stock that will be outstanding immediately after this offering as shown above is based on 180,317,751 shares outstanding as of September 30, 2020.
From July 1, 2020 to September 30, 2020
Conversion of preferred stock to common stock
Exercise of stock options
Capital raises
From July 1, 2019 to June 30, 2020
Sales of Series C Preferred and common stock
Conversion of preferred stock to common stock
Compensation shares
Exercise of warrants
Exercise of stock options
Warrant exchange and deemed dividend
From December 31, 2019 to March 31, 2020
Warrant exchange
Capital raise
Compensation shares
Exercise of warrants
Exercise of stock options
Conversion of preferred stock to common stock
From September 30, 2019 to December 31, 2019
Capital raise
Compensation shares
Exercise of warrants
Conversion of preferred stock to common stock
From June 30, 2019 to September 30, 2019
Conversion of preferred stock to common stock
from July 1, 2018 to June 30, 2019
Conversion of preferred stock to common stock
Issuance of common stock to underwriters
from December 31, 2018 to March 31, 2019
Conversion of preferred stock to common stock
Issuance of common stock to underwriters
From July 1, 2018 to December 31, 2018
Sales of common stock
Conversion of preferred stock to common stock
From July 1, 2018 to September 30, 2018
Conversion of preferred stock to common stock
Sale of common stock
From July 1, 2017 to June 30, 2018
Sales of preferred stock
Sales of common stock
Commitment fees for issuance of common stock
Cash in lieu for fractional shares
Conversion of preferred stock to common stock
IBIO, INC.(NYSE AMERICAN:IBIO) announced today a reverse split of its Common Stock, par value $0.001 per share (the "Common Stock"), at a ratio of 1 for 10, effective on June 8, 2018 (the "Effective Date"). The Company's common stock will continue to trade on the New York Stock Exchange under the trading symbol "IBIO" but will trade under the new CUSIP number 451033 203. As a result of the reverse split, each ten pre-split shares of common stock outstanding will automatically combine into one new share of common stock without any action on the part of the holders, and the number of outstanding common shares will be reduced from 115,918,510 shares to 11,591,851 shares.
From July 1, 2017 To March 31, 2018
Sales of common stock
Commitment fees for issuance of common stock
From July 1, 2017 To December 31, 2017
Sale of common stock
Commitment fee for issuance of common stock
From July 1, 2017 To September 30, 2017
Sale of common stock
Commitment fee for issuance of common stock
From July 1, 2016 to March 31, 2017
Other adjustment
From July 1, 2015 to June 30, 2016
Sale of common stock
Exercises of warrants
from July 1, 2015 to March 31, 2016
Sale of common stock
Exercises of warrants
from July 1, 2015 to September 30, 2015
Exercise of warrants
from July 1, 2014 to June 30, 2015
Sale of common stock
Commitment fee
Exercises of warrants
from July 1, 2014 to March 31, 2015
Sale of common stock
Commitment fee
Exercises of warrants
from July 1, 2014 to December 31, 2014
Sale of common stock
Commitment fee
Exercises of warrants
from July 1, 2014 to September 30, 2014
Capital contribution and commitment fee
from June 30, 2013 to June 30, 2014
Common stock issued for warrant exercises
Common stock issued for private placement
from July 1, 2013 to December 31, 2013
Common stock issued for warrant exercises
from June 30, 2012 to May 15, 2013
Issuance of common stock in connection with January 2012 equity offering, net of expenses
from June 30, 2011 to February 14,2012
Issuance of common stock and warrants in January 2012, at $0.65 per unit, net of expenses
from June 30 2010 to March 31 2011
Issuance of common stock and warrants between October 27, 2010 and November 22, 2010 for cash at $2.00 per unit, net of expenses
Issuance of common stock between October 27, 2010 and November 22, 2010 in accordance with anti-dilution provisions of the August 2008 financing
Issuance of common stock in connection with exercise of warrants
from June 30 2010 to December 31 2010
Issuance of common stock and warrants for cash at $2.00 per unit, net of expenses
Issuance of common stock in accordance with anti-dilution provisions of the August 2008 financing
from June 30 2009 to March 31 2010
Issuance of common stock and warrants for cash at $0.65 per unit, net of expenses
Issuance of common stock in accordance with anti-dilution provisions of the August 2008 financing